Cedar Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-21,032
| Closed | -$732K | – | 145 |
|
2020
Q3 | $732K | Buy |
21,032
+7,687
| +58% | +$268K | 0.24% | 103 |
|
2020
Q2 | $414K | Sell |
13,345
-97
| -0.7% | -$3.01K | 0.16% | 121 |
|
2020
Q1 | $416K | Sell |
13,442
-5,691
| -30% | -$176K | 0.2% | 107 |
|
2019
Q4 | $711K | Buy |
19,133
+3,275
| +21% | +$122K | 0.33% | 102 |
|
2019
Q3 | $541K | Buy |
15,858
+1,004
| +7% | +$34.3K | 0.25% | 112 |
|
2019
Q2 | $611K | Buy |
14,854
+514
| +4% | +$21.1K | 0.26% | 99 |
|
2019
Q1 | $578K | Sell |
14,340
-548
| -4% | -$22.1K | 0.25% | 107 |
|
2018
Q4 | $617K | Buy |
14,888
+1,094
| +8% | +$45.3K | 0.31% | 85 |
|
2018
Q3 | $577K | Buy |
13,794
+895
| +7% | +$37.4K | 0.22% | 109 |
|
2018
Q2 | $444K | Buy |
12,899
+1,629
| +14% | +$56.1K | 0.2% | 101 |
|
2018
Q1 | $379K | Buy |
11,270
+1,431
| +15% | +$48.1K | 0.18% | 101 |
|
2017
Q4 | $338K | Buy |
9,839
+1,590
| +19% | +$54.6K | 0.16% | 92 |
|
2017
Q3 | $279K | Sell |
8,249
-554
| -6% | -$18.7K | 0.13% | 90 |
|
2017
Q2 | $281K | Buy |
8,803
+2,115
| +32% | +$67.5K | 0.12% | 75 |
|
2017
Q1 | $217K | Buy |
+6,688
| New | +$217K | 0.09% | 92 |
|